ACADIA Pharmaceuticals Inc. & SUPERVALU Inc. Announcements: (NASDAQ: ACAD), (NYSE: SVU)
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) announced that Jeffrey Cummings, M.D., Sc.D., Director of Cleveland Clinic Lou Ruvo Center for Brain Health, presented detailed results from ACADIA’s pivotal Phase III -020 Study with pimavanserin in patients with Parkinson’s disease psychosis at the Emerging Science session of the 65th American Academy of Neurology (AAN) Annual Meeting.
View full press release